Clinical Nutrition for Diabetes Care

Global Clinical Nutrition for Diabetes Care Market to Reach US$2.7 Billion by 2030

The global market for Clinical Nutrition for Diabetes Care estimated at US$2.2 Billion in the year 2024, is expected to reach US$2.7 Billion by 2030, growing at a CAGR of 3.6% over the analysis period 2024-2030. Oral Nutrition, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$1.5 Billion by the end of the analysis period. Growth in the Enteral Feeding Formulas segment is estimated at 3.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$596.0 Million While China is Forecast to Grow at 6.8% CAGR

The Clinical Nutrition for Diabetes Care market in the U.S. is estimated at US$596.0 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$545.1 Million by the year 2030 trailing a CAGR of 6.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.4% and 2.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.1% CAGR.

Global Clinical Nutrition for Diabetes Care Market – Key Trends & Drivers Summarized

Why Is Clinical Nutrition Becoming Central to Effective Diabetes Management?

Clinical nutrition has become a cornerstone in the holistic management of diabetes, a chronic metabolic disorder that affects hundreds of millions of people globally. As the prevalence of both Type 1 and Type 2 diabetes continues to rise—driven by sedentary lifestyles, poor dietary habits, genetic predisposition, and increasing obesity rates—nutritional therapy is playing a critical role in regulating blood glucose levels, improving insulin sensitivity, and preventing complications. Unlike general dietary guidelines, clinical nutrition for diabetes care involves precisely formulated therapeutic products that are designed to meet the metabolic and glycemic needs of diabetic patients. These specialized nutritional interventions not only help control carbohydrate intake and glycemic spikes but also support micronutrient balance, manage coexisting conditions such as cardiovascular diseases, and prevent malnutrition, which is common among elderly diabetic populations. Increasing awareness among healthcare providers and patients about the pivotal role of nutrition in disease control is making clinical nutrition an integral part of diabetes care pathways, both in institutional and home-based settings.

How Are Formulation Innovations and Delivery Formats Transforming the Market Landscape?

The clinical nutrition for diabetes care market is rapidly evolving through technological advancements in formulation science and the introduction of diverse, patient-friendly delivery formats. Manufacturers are developing scientifically balanced nutrition solutions that contain low glycemic index carbohydrates, high-quality protein, dietary fiber, healthy fats, and essential micronutrients tailored specifically for glycemic control and metabolic health. Diabetic-specific nutrition supplements—available as ready-to-drink beverages, powders, snack bars, meal replacements, and enteral feeding formulas—are being designed to provide controlled energy intake while avoiding sugar spikes. Novel ingredients such as slowly digestible starches, prebiotics, chromium picolinate, omega-3 fatty acids, and plant-based proteins are being incorporated to enhance efficacy and satiety. Formulations are increasingly free from added sugars, trans fats, and artificial additives, aligning with clean-label and functional nutrition trends. Enhanced palatability, ease of digestion, and texture optimization are improving patient compliance, particularly among geriatric and pediatric diabetic populations. Additionally, advances in smart packaging, portion control sachets, and personalized meal kits are expanding accessibility and convenience for patients managing diabetes in daily life.

What Role Do Population Health Trends, Care Models, and Regional Dynamics Play in Shaping Market Demand?

Population health trends and evolving models of care are deeply influencing the clinical nutrition market for diabetes management. The rising global burden of diabetes—especially in low- and middle-income countries across Asia-Pacific, Africa, and Latin America—has led to an urgent need for scalable, affordable, and culturally adaptable nutritional solutions. In developed markets such as North America and Europe, where diabetes prevalence is high among older adults, the focus is on personalized nutrition and integration of clinical nutrition into chronic care pathways and home health services. As multidisciplinary care models become standard in diabetes treatment, registered dietitians, nutritionists, and diabetes educators are playing a central role in patient care teams. Community-based diabetes prevention programs and public health campaigns are also promoting early-stage dietary intervention, driving demand for clinically validated nutritional products. Hospital nutrition protocols, insurance reimbursement frameworks, and government nutrition subsidy programs are supporting the broader adoption of diabetes-specific nutrition in both outpatient and inpatient settings. Regional preferences for plant-based diets, local flavors, and dietary restrictions are also influencing product development strategies and creating a need for localized product formulations.

What Are the Primary Growth Drivers Powering the Clinical Nutrition for Diabetes Care Market?

The growth in the clinical nutrition for diabetes care market is driven by several factors directly linked to scientific innovation, changing consumer behavior, evolving healthcare infrastructure, and increasing demand for personalized disease management solutions. The escalating global incidence of diabetes is a primary market driver, pushing healthcare systems to adopt preventative and supportive nutritional therapies. Continuous advancements in formulation technologies—such as low glycemic index carbohydrate blends, bioavailable micronutrients, and diabetes-specific protein matrices—are making clinical nutrition products more effective and therapeutically relevant. The increasing integration of clinical nutrition into standard care protocols across hospitals, outpatient clinics, and home healthcare settings is expanding institutional demand. Rising health awareness among consumers and a growing preference for non-pharmacological and nutrition-led interventions are fueling individual demand for specialized diabetic nutrition. Additionally, the growth of digital health tools, tele-nutrition platforms, and app-based nutrition monitoring is enabling more personalized and data-driven dietary planning. Strategic collaborations between food science companies and healthcare providers, coupled with supportive regulatory policies and reimbursement models, are further enhancing market scalability. Moreover, the proliferation of e-commerce platforms and D2C nutrition brands is improving accessibility, driving consumer engagement, and accelerating the overall growth trajectory of the clinical nutrition for diabetes care market.

SCOPE OF STUDY:

The report analyzes the Clinical Nutrition for Diabetes Care market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Product Type (Oral Nutrition, Enteral Feeding Formulas, Parenteral Nutrition); Distribution Channel (Institutional Distribution Channel, Retail Distribution Channel, Online Distribution Channel)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

• Abbott Laboratories
• Baxter International Inc.
• Bayer AG
• Danone Nutricia
• GlaxoSmithKline plc (GSK)
• Hero Nutritionals
• Joslin Diabetes Center
• Lonza Capsules & Health Ingredients
• Mead Johnson & Company, LLC
• Medtronic
• Montmed
• Nestlé Health Science
• Novo Nordisk
• Otsuka Holdings Co., Ltd.
• Perrigo Company plc
• Pfizer Inc.
• Reckitt Benckiser Group PLC
• Sanofi
• Victus, Inc.
• Virta Health

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.